Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Iterum Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ITRM.
You can purchase shares of Iterum Therapeutics (NASDAQ:ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI), VYNE Therapeutics (NASDAQ:VYNE) and Nutriband (NASDAQ:NTRB).
Iterum Therapeutics has a consensus price target of $5.00.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.41 last updated March 14, 2025 at 5:01 PM EDT.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.